SGI-1776
SGI-1776 has been used in trials studying the treatment of Prostate Cancer, Non-Hodgkins Lymphoma, and Relapsed/Refractory Leukemias.
| Catalog Number | T3078 |
| Alternative Name(s) | SGI-1776 free base , Pim-Kinase Inhibitor IX |
| Research Area | Chromatin/Epigenetic|||JAK/STAT signaling|||Tyrosine Kinase/Adaptors|||Apoptosis|||Autophagy|||Angiogenesis |
| Molecular Formula | C20H22F3N5O |
| CAS# | 1025065-69-3 |
| Purity | 99.30% |
| SMILES | CN1CCC(CNc2nn3c(cc2)ncc3c2cc(OC(F)(F)F)ccc2)CC1 |
| Size | 2 mg |
| Supplier Page | https://www.targetmol.com/compound/SGI-1776 |
| Additional Information | https://www.targetmol.com/datasheet/T3078 |